Scientists at Johns Hopkins University have discovered that in the early stages of Alzheimer's disease, two brain regions—the entorhinal cortex and the amygdala—begin to shrink before the hippocampus, where signs of the disease are usually sought. The findings were published in the journal NeuroImage Reports.

The researchers analyzed hundreds of MRI and PET scans from two independent groups of participants at different stages of the disease. In both groups, the entorhinal cortex and the amygdala showed greater volume loss in the early stages of the disease than the hippocampus.

The entorhinal cortex is involved in retrieving memories, while the amygdala is associated with emotional memory. Reduced gray matter volume in these regions was also linked to changes in tau protein—one of the hallmarks of Alzheimer's disease.

According to the study's senior author, biomedical engineer Michael Miller, brain changes may become noticeable five to ten years before clinical symptoms appear. The scientists hope that measuring the volume of these regions will help identify people at increased risk of the disease and allow treatment to begin earlier, when it may be more effective.

For now, the proposed approach is not ready for use as a diagnostic method: further research is needed to confirm its accuracy and clinical relevance.